These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam. Barbaud A; Trechot P; Reichert-Penetrat S; Granel F; Schmutz JL Contact Dermatitis; 2001 Apr; 44(4):259-60. PubMed ID: 11336014 [No Abstract] [Full Text] [Related]
12. Tetrazepam Allergy: A Case Series of Cutaneous Adverse Events. Huseynov I; Wirtz M; Hunzelmann N Acta Derm Venereol; 2016 Jan; 96(1):110-1. PubMed ID: 26012498 [No Abstract] [Full Text] [Related]
13. Cross-reactive type IV hypersensitivity reactions to benzodiazepines revealed by patch testing. Kämpgen E; Bürger T; Bröcker EB; Klein CE Contact Dermatitis; 1995 Nov; 33(5):356-7. PubMed ID: 8565501 [No Abstract] [Full Text] [Related]
14. Repeated patch testing in penicillin allergy. Bruynzeel DP; van Ketel WG Br J Dermatol; 1981 Feb; 104(2):157-9. PubMed ID: 6452155 [TBL] [Abstract][Full Text] [Related]
15. Occupational allergic contact dermatitis from tetrazepam in nurses. Vander Hulst K; Kerre S; Goossens A Contact Dermatitis; 2010 May; 62(5):303-8. PubMed ID: 20536478 [TBL] [Abstract][Full Text] [Related]
16. Acute generalized exanthematous pustulosis due to tetrazepam. Thomas E; Bellón T; Barranco P; Padial A; Tapia B; Morel E; Alves-Ferreira J; Martín-Esteban M J Investig Allergol Clin Immunol; 2008; 18(2):119-22. PubMed ID: 18447141 [TBL] [Abstract][Full Text] [Related]
18. Patch tests in drug eruptions. Houwerzijl J; de Gast GC; Nater JP Contact Dermatitis; 1975 Jun; 1(3):180-1. PubMed ID: 138508 [No Abstract] [Full Text] [Related]
19. Patch testing for leg ulcer patients. Cameron J Nurs Times; 1990 Jun 20-26; 86(25):63-4. PubMed ID: 2141690 [No Abstract] [Full Text] [Related]
20. [Neither skin tests nor challenge tests are sufficient to provide formal diagnosis of drug allergy or sensitisation. A discussion of the article "Two medicines of similar imputability in dermal adverse drug reactions (two cases): the limitations of epicutaneous testing?" by P. Dellestable et al]. Augey F; Guneraa-Saad N; Bérard F; Nicolas JF Ann Dermatol Venereol; 2008 Dec; 135(12):867-8. PubMed ID: 19084703 [No Abstract] [Full Text] [Related] [Next] [New Search]